Search Results - A. Moskowitz
- Showing 1 - 9 results of 9
-
1
129 | PEMBROLIZUMAB AND RADIATION THERAPY ALONE AS AN ALTERNATIVE TO TRANSPLANT FOR LOCALIZED FAILURE AFTER CHEMOTHERAPY IN HODGKIN LYMPHOMA: A MULTICENTER PHASE II STUDY by A. D. Dreyfuss, N. Ganesan, B. S. Imber, M. LaRiviere, D. Isrow, J. Plastaras, J. Svoboda, J. Yahalom, C. H. Moskowitz, A. Moskowitz
Published 2025Get full text
Artículo Open Access -
2
853 | CTEP TRIAL 10590, NORM: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA PATIENTS TREATED IN A RANDOMIZED PHASE II TRIAL WITH EITHER RITUXIMAB OR MOSUNETUZUMAB by R. Steiner, A. M. Bock, A. F. Herrera, O. Zulfa, M. Hoffmann, S. Ibrahimi, N. Galanina, H. J. Lee, M. Green, R. Lin, C. C. Pinnix, A. Moskowitz, J. Yahalom, D. Chihara
Published 2025Get full text
Artículo Open Access -
3
734 | REAL‐WORLD OUTCOMES OF FRONTLINE BRENTUXIMAB VEDOTIN IN OLDER PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐AN INTERNATIONAL, MULTI‐CENTER STUDY by E. Luttwak, S. Kambhampati Thiruvengadam, E. Drill, N. Ganesan, l. Hofstetter, R. Gurion, S. Auman, M. Geva, M. Panossian, R. Stuver, P. Hamlin, A. Noy, P. Torka, G. Salles, A. F. Herrera, A. Moskowitz
Published 2025Get full text
Artículo Open Access -
4
757 | INCIDENCE OF MYELOID NEOPLASMS IN PATIENTS WITH T‐FOLLICULAR HELPER CELL LYMPHOMAS by K. S. Lin, N. Ganesan, M. Yan, T. Chang, A. Dogan, Z. Epstein‐Peterson, O. C. Eren, P. Ghione, S. Horwitz, V. Iyengar, W. Johnson, K. Ksanznak, A. Moskowitz, B. Sordi, W. Xiao, R. Stuver
Published 2025Get full text
Artículo Open Access -
5
394 | RUXOLITINIB TARGETS STAT1‐STAT3 COOPERATIVELY IN LARGE GRANULAR LYMPHOCYTIC LEUKEMIA by A. Marouf, S. Grassmann, J. Rahman, N. Ganesan, P. Berning, Y. Lin, P. Torka, A. Kumar, O. Eren, T. Zhou, A. Dogan, J. Sun, M. Lim, K. Elenitoba‐Johnson, A. Zelenetz, S. Horwitz, G. Salles, A. Moskowitz, S. A. Vardhana
Published 2025Get full text
Artículo Open Access -
6
418 | CIRCULATING TUMOR DNA ASSESSMENT IN PATIENTS WITH EARLY‐STAGE CLASSICAL HODGKIN LYMPHOMA TREATED WITH COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB by R. C. Lynch, N. L. Bartlett, J. M. Burke, Y. Linhares, E. Domingo Domenech, W. Jurczak, U. Hahn, H. J. Lee, R. Ramchandren, A. Moskowitz, C. A. Yasenchak, H. Prince, J. Yao, W. Guo, M. Fanale, G. Davis, E. Rustia, L. Ho, H. Lu, J. S. Abramson
Published 2025Get full text
Artículo Open Access -
7
182 | GENOMIC TESTING IN PATIENTS WITH LARGE CELL AND FOLLICULAR LYMPHOMA TREATED WITH T‐CELL ENGAGERS BI‐SPECIFIC ANTIBODIES AND CORRELATION WITH TREATMENT RESPONSE by R. Tavarozzi, A. Rivas Delgado, M. Okwali, M. E. Arcila, A. Qiu, E. Luttwak, A. Boardman, R. Stuver, J. Lue, C. Owens, P. Torka, A. Kumar, S. Vardhana, R. Steiner, K. David, P. Hamlin, S. Horwitz, A. Moskowitz, W. Johnson, Z. Epstein‐Peterson, J. Zain, P. Caron, M. L. Palomba, A. Noy, A. Zelenetz, G. Salles, P. Ghione
Published 2025Get full text
Artículo Open Access -
8
858 | OPTIMIZING FRONTLINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA IN OLDER ADULTS: A GLOfitamab‐BASED, RESPONSE‐ADAPTED, WINDOW‐StYle STUDY (GLORY) by P. Torka, K. Alexander, K. McConnell, V. Seshan, J. Tortora, H. Levenstein, O. Kelly, H. Jacob, W. Ramos Amador, J. Kiernan, R. Truong, P. Caron, A. Boardman, K. David, Z. Epstein‐Peterson, L. Falchi, P. Ghione, S. Horwitz, A. Intlekofer, W. Johnson, A. Kumar, J. Lue, E. Luttwak, A. Moskowitz, A. Noy, C. Owens, M. Palomba, R. Steiner, R. Stuver, S. Vardhana, J. Zain, A. Zelenetz, G. Salles, P. Hamlin
Published 2025Get full text
Artículo Open Access -
9
120 | DETECTION OF INTRATUMORAL MICROORGANISMS AND THEIR IMPACT ON OUTCOMES IN UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA by P. Ghione, C. Vanderbilt, T. Fei, T. Rita, A. Rivas Delgado, A. Qiu, M. Okwali, M. Uppal, R. Shouval, A. P. Boardman, P. Caron, K. David, Z. Epstein‐Peterson, L. Falchi, P. Hamlin, S. Horwitz, A. Intlekofer, W. Johnson, A. Kumar, J. Lue, E. Luttwak, A. Moskowitz, A. Noy, C. Owens, M L. Palomba, R. Steiner, R. Stuver, P. Torka, S. Vardhana, J. Zain, A. Zelenetz, I. Giorgio, M. Arcila, J. Peled, M. Lim, G. Salles
Published 2025Get full text
Artículo Open Access